Gainers: Conifer Holdings (CNFR) +46%. FG Financial Group (FGF) +31%. Qudian (QD) +18%. X Financial (XYF) +14%. Hudson Capital (HUSN) +14%.Losers: China Finance Online (JRJC) -23%. Rand Capital (RAND) -15%. Big Rock Partners Acquisition (BRPA) -13%. Tottenham Acquisition I (TOTA) -10%. ATIF H...
Gainers: ATIF Holdings (ATIF) +109%. Diginex (EQOS) +26%. Ashford Hospitality Trust (AHT) +24%. Tottenham Acquisition I (TOTA) +22%. Marathon Patent Group (MARA) +19%.Losers: Upstart Holdings (UPST) -11%. Lemonade (LMND) -10%. InterPrivate Acquisition (IPV) -9%. Northern Star Acquisition...
WeissLaw LLP Reminds CPAA, TOTA, and LFAC Shareholders About Its Ongoing Investigations PR Newswire NEW YORK, Oct. 16, 2020 NEW YORK , Oct. 16, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to...
NEW YORK , Sept. 10, 2020 /PRNewswire/ -- Tottenham Acquisition I Limited (Nasdaq: TOTA, TOTAU, TOTAW, TOTAR) ("Tottenham"), a publicly traded special purpose acquisition company, announced today that its subsidiary, Chelsea Worldwide Inc., has filed with the U.S. Securities and Exchang...
Clene is a clinical-stage biopharmaceutical company developing the first potential therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the n...
Don’t Double Count I am sympathetic to most bearish sentiments (see here and here ), but am trying to be careful to not double count our problems. For example, I am quite concerned about Covid-19, but am wary of a lot of the statistics floating around the media. For example, some...
News, Short Squeeze, Breakout and More Instantly...
Tottenham Acquisition I Limited Company Name:
TOTA Stock Symbol:
NASDAQ Market:
NEW YORK , Sept. 10, 2020 /PRNewswire/ -- Tottenham Acquisition I Limited (Nasdaq: TOTA, TOTAU, TOTAW, TOTAR) ("Tottenham"), a publicly traded special purpose acquisition company, announced today that its subsidiary, Chelsea Worldwide Inc., has filed with the U.S. Securities and Exchang...
Clene is a clinical-stage biopharmaceutical company developing the first potential therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the n...